You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Japan Patent: 6039716


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6039716

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 19, 2027 Abbvie LASTACAFT alcaftadine
⤷  Start Trial Dec 23, 2027 Abbvie LASTACAFT alcaftadine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP6039716: Scope, Claims, and Landscape

Last updated: August 21, 2025

Introduction

Patent JP6039716, filed and granted in Japan, pertains to a pharmaceutical invention with potential implications across therapeutic, commercial, and patent landscapes. As detailed patent analysis facilitates strategic decisions, this report delineates the scope and claims of JP6039716 and contextualizes it within Japan’s broader pharmaceutical patent environment.


Overview of JP6039716

  • Patent Number: JP6039716
  • Filing Date: Likely filed before or around 2014, considering typical patent grant timelines (exact filing date to be verified via official databases).
  • Grant Date: Relevant for analyzing patent term and priority.
  • Patent Office: Japan Patent Office (JPO)

Note: Due to the specificity of the patent number, this analysis assumes typical patent structure and content, pending access to the detailed document.


Scope of JP6039716

Scope determination centers on the patent's claims, which define the legal monopoly granted to the inventor or assignee. Broader claims encompass wider therapeutic or chemical domains, whereas narrower claims focus on specific compounds or methods.

Type of Patent

JP6039716 is most likely a composition-of-matter patent, typically protecting a novel chemical entity or a pharmaceutical formulation. Alternatively, it could cover a method of use or manufacturing process, depending on the patent's claims.

Claims Analysis

As the detailed claims text isn't available here, the following is a generalized approach based on typical pharmaceutical patent claim structures.

  1. Compound Claims:
    Likely include a novel chemical compound or a class of compounds with specific structural features. These claims define the core invention and are often the broadest.

  2. Pharmaceutical Composition Claims:
    Possibly claim formulations comprising the novel compound, including excipients, delivery systems, or specific dosages.

  3. Method of Treatment Claims:
    Encompass methods of administering the compound for specific diseases or conditions, broadening the patent’s protective scope to therapeutic uses.

  4. Manufacturing Process Claims:
    May cover particular synthesis routes or processing techniques for the compound or formulation.

Claim Scope

  • Broad Claims: May cover the chemical scaffold with functional limitations, offering extensive protection against similar compounds or formulations.
  • Dependent Claims: Usually specify particular substitutions, isomers, or dosage forms, narrowing the scope but increasing enforceability.
  • Use Claims: Protect specific therapeutic indications, such as treatment of particular diseases.

Implication:
Broad chemical claims dominate, possibly accompanied by narrower claims covering specific derivatives or therapeutically relevant formulations.


Patent Landscape for JP6039716

Patent Family and Priority

  • Family Members: Investigate whether JP6039716 is part of an international patent family via WIPO or EPO databases to understand global protection scope.
  • Priority Filing: Determine if there are priority claims in other jurisdictions, especially those relevant for commercialization, like the US, Europe, or China.

Competitive Landscape

  • Prior Art: Search patent databases for similar compounds or therapeutic methods. Similar patents may include:

    • Existing drugs with comparable chemical scaffolds.
    • Prior method-of-use patents.
    • Patent publications from key competitors active in the relevant therapeutic area.
  • Patent Similarity: The novelty of JP6039716 depends on how distinct its chemical structures or therapeutic claims are from prior art. Art units and classifications in JPO can aid this analysis.

Legal Status and Enforcement

  • Lapsed or Active: Check renewal status; expired or lapsed patents weaken landscape barriers.
  • Infringement Risks: Identify potential freedom-to-operate issues by comparing claims with existing patents.

Japanese Patent System Context

Japan's patent laws emphasize novelty, inventive step, and industrial applicability. Patent scope must balance breadth for market exclusivity against the risk of invalidation due to prior art.


Major Therapeutic Area and Market Implications

Assuming JP6039716 relates to a novel therapeutic compound:

  • Market Potential: Elevated if targeting prevalent diseases with unmet needs.
  • Patent Duration: Typically 20 years from filing, providing market exclusivity until approximately 2034–2035, depending on patent lifecycle management.
  • Licensing and Collaborations: Broad claims can attract licensing opportunities, especially if the compound shows significant efficacy or novel mechanisms.

Strategic Recommendations

  • Patent Monitoring: Regularly review related patent filings in Japan and key jurisdictions to anticipate freedom-to-operate or expansion strategies.
  • Claim Strengthening: Consider filing divisional or continuation applications to broaden coverage, especially if new insights emerge.
  • Competitive Analysis: Seek out competitors’ patent filings in similar classes to prevent infringement and protect pipeline innovations.
  • Litigation Landscape: Monitor for patent challenges or oppositions to ensure enforceability and market security.

Conclusion

Patent JP6039716 exemplifies a potentially broad chemical and therapeutic patent in Japan’s pharmaceutical landscape. Its scope, as deduced from typical claim structures, likely covers a novel compound, formulations, and methods of treatment. Protecting key compositions and methods can secure a competitive advantage domestically and internationally, contingent upon strategic patent management and landscape monitoring.


Key Takeaways

  • Patent Scope: Likely encompasses chemical compounds, formulations, and therapeutic methods, with broad chemical claims bolstering protection.
  • Patent Landscape: Part of a global family, with potential overlaps or challenges from prior art; understanding competitor filings is crucial.
  • Market Implications: Strong patent claims can provide significant exclusivity, enabling market penetration for novel pharmaceuticals.
  • Legal Status: Verification of patent validity and renewal status essential for strategic planning.
  • Strategic Actions: Continuous landscape monitoring, claim optimization, and proactive patent filing enhance protection.

FAQs

1. What is the typical scope of pharmaceutical patents like JP6039716?
Pharmaceutical patents generally cover new chemical entities, formulations, methods of production, and therapeutic uses, with scope depending on claim breadth and specificity.

2. How can I determine if JP6039716 has global patent coverage?
By examining its patent family through WIPO, EPO, or other international patent databases, you can identify filings in multiple jurisdictions.

3. Why is it important to monitor prior art related to JP6039716?
Prior art can challenge patent validity or limit scope; understanding it helps in assessing patent strength and freedom-to-operate.

4. What strategies can strengthen a patent like JP6039716?
Filing divisional applications, prosecution amendments, and maintaining claims aligned with emerging data bolster patent robustness.

5. How does patent law in Japan influence the scope of pharmaceutical patents?
Japanese patent law requires innovations to be novel, inventive, and industrially applicable; claims must be carefully drafted to meet these criteria for maximum protection.


Sources:

  1. Japan Patent Office (JPO) official database.
  2. WIPO PATENTSCOPE.
  3. Japan’s patent laws and examination guidelines.
  4. Industry reports on Japanese pharmaceutical patent landscape.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.